Skip to content

Granted (in shares) at other companies

Repligen logo
RepligenRGEN
$125.03
Genpact logo
GenpactG
$0.00
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$10.29
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$32.52
Scansource logo
ScansourceSCSC
$0.00
Emerald Holding logo
Emerald HoldingEEX
$4.30

Other financials

Income statement

See full
Revenue$26.2M+14.7%
Net income$9.4M+22.1%
EPS (diluted)$0.51+34.2%

Balance sheet

See full
Cash & equivalents$79.0M-19.4%
Total debt$4.8M-38.3%
Total equity$223.2M-0.8%
Total assets$2.8B+6.3%

Cash flow

See full
Operating cash flow$15.3M+4.4%
CapEx$320.0K+596%
Free cash flow$15.0M+2.6%

Valuation

See full
Market cap$363.27M+13.5%
Enterprise value$289.06M+25.8%
P/E13.1×+1.5×
P/S3.9×+0.2×

Profitability

See full
Net margin29.7%-1.8pp
FCF margin55.3%

Returns & leverage

See full
Return on equity12.4%-0.8pp
Debt / equity0.0×

Where this comes from

Reported directly by USCB Financial Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: USCB Financial Holdings, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about USCB Financial Holdings, Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USCB Financial Holdings, Inc.'s granted (in shares)?
USCB Financial Holdings, Inc. (USCB) reported granted (in shares) of $0 in Q4 2025.
What does granted (in shares) mean?
The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.